Back to Results
First PageMeta Content
Financial ratios / Business / Fundamental analysis / Valuation / Income / Earnings before interest / taxes / depreciation and amortization / Net profit / Times interest earned / Cash flow statement / Finance / Accountancy / Generally Accepted Accounting Principles


Microsoft Word - Sun Pharma - Q2FY11 Results Review 02Nov10.doc
Add to Reading List

Document Date: 2010-11-02 03:38:57

Open Document

File Size: 241,51 KB

Share Result on Facebook

City

Mumbai / /

Company

Results Review Sun Pharmaceutical Industries Ltd / Religare Capital Markets plc / HOLD Sun Pharmaceutical / BLOOMBERG / Religare Capital Markets Ltd / FY11E / London Stock Exchange / SUNPHARMA SUNP IN Company / Sun Pharmaceutical Industries Ltd / Sun Pharma / /

Country

Japan / United States / Canada / Australia / United Kingdom / South Africa / India / Ireland / /

Currency

USD / /

/

Event

Earnings Guidance / Analyst Recommendation / /

IndustryTerm

corporate finance advice / investment services / /

MarketIndex

Sensex 20 / /

Organization

FSA / Financial Services Authority / /

Person

Nicholas Malins-Smith / /

/

Position

broker / analyst / /

Product

Eloxatin / Promoters 63.7 63.7 63.7 / /

ProvinceOrState

Prince Edward Island / /

Technology

CMP / /

SocialTag